am 251 and pf 3845
am 251 has been researched along with pf 3845 in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bradshaw, HB; Cygankiewicz, A; Fichna, J; Kordek, R; Krajewska, WM; Leishman, E; Małecka-Panas, E; Mokrowiecka, A; Sałaga, M; Sobczak, M; Storr, M; Zakrzewski, PK; Zatorski, H | 1 |
| Barna, L; Dudok, B; Henstridge, CM; Horvai, G; Katona, I; Kenesei, K; Ledri, M; Lee, SH; Limoli, CL; Marchionni, I; Oberoi, M; Renkecz, T; Soltesz, I; Szabó, SI; Tóth, B; Watanabe, M | 1 |
| Fichna, J; Misicka, A; Sacharczuk, M; Wasilewski, A | 1 |
Other Studies
3 other study(ies) available for am 251 and pf 3845
| Article | Year |
|---|---|
Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH).
Topics: Amidohydrolases; Animals; Cannabinoids; Colitis, Ulcerative; Disease Models, Animal; Dose-Response Relationship, Drug; Indoles; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Piperidines; Pyrazoles; Pyridines; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Treatment Outcome | 2014 |
Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release.
Topics: Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Endocannabinoids; Enzyme Inhibitors; Female; gamma-Aminobutyric Acid; Glycerides; Hippocampus; Inhibitory Postsynaptic Potentials; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Piperidines; Pyrazoles; Pyridines; Receptor, Cannabinoid, CB1; Signal Transduction; Synapses; TRPV Cation Channels | 2015 |
Modulation of the endocannabinoid system by the fatty acid amide hydrolase, monoacylglycerol and diacylglycerol lipase inhibitors as an attractive target for secretory diarrhoea therapy.
Topics: Amidohydrolases; Animals; Benzodioxoles; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cyclohexanones; Diarrhea; Endocannabinoids; Enzyme Inhibitors; Indoles; Lipoprotein Lipase; Male; Mice; Monoglycerides; Piperidines; Pyrazoles; Pyridines; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2017 |